Advertisement
Screener

PAVmed Inc. (PAVM) Net Income (Loss) Attributable to Noncontrolling Interest

1.8 / 5 stars · 20/56 Roast Me

PAVmed Inc. Net Income (Loss) Attributable to Noncontrolling Interest

PAVmed Inc. (PAVM) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$1.21 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-13

  • PAVmed Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$1.21M.
  • PAVmed Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$1.00M.
  • PAVmed Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$1.49M.
  • PAVmed Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$628.00K.
  • PAVmed Inc. net income (loss) attributable to noncontrolling interest for fiscal 2025 was -$2.87M.
  • PAVmed Inc. net income (loss) attributable to noncontrolling interest for fiscal 2024 was -$11.36M.
  • PAVmed Inc. net income (loss) attributable to noncontrolling interest for fiscal 2023 was -$15.09M.
  • PAVmed Inc. net income (loss) attributable to noncontrolling interest for fiscal 2022 was -$14.26M.
Period endNet Income (Loss) Attributable to Noncontrolling Interest 3 monthNet Income (Loss) Attributable to Noncontrolling Interest 3 month as first filedNet Income (Loss) Attributable to Noncontrolling Interest 6 monthNet Income (Loss) Attributable to Noncontrolling Interest 6 month as first filedNet Income (Loss) Attributable to Noncontrolling Interest 9 monthNet Income (Loss) Attributable to Noncontrolling Interest 9 month as first filedNet Income (Loss) Attributable to Noncontrolling Interest 12 monthNet Income (Loss) Attributable to Noncontrolling Interest 12 month as first filed
2026-06-30-$1.21M
10-Q · filed 2026-08-13
-$2.22M
10-Q · filed 2026-08-13
-$3.71M
derived: sum of 3 quarters · filed 2026-08-13
-$4.34M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31-$1.00M
10-Q · filed 2026-05-14
-$2.50M
derived: sum of 2 quarters · filed 2026-05-14
-$3.13M
derived: sum of 3 quarters · filed 2026-05-14
-$3.53M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31-$1.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
-$2.12M
derived: sum of 2 quarters · filed 2026-03-27
-$2.52M
derived: sum of 3 quarters · filed 2026-08-13
-$2.87M
10-K · filed 2026-03-27
2025-09-30-$628.00K
10-Q · filed 2025-11-12
-$1.03M
derived: sum of 2 quarters · filed 2026-08-13
-$1.38M
10-Q · filed 2025-11-12
-$1.67M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30-$403.00K
10-Q · filed 2026-08-13
-$747.00K
10-Q · filed 2026-08-13
-$1.04M
derived: sum of 3 quarters · filed 2026-08-13
-$4.72M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31-$345.00K
10-Q · filed 2026-05-14
-$634.00K
derived: sum of 2 quarters · filed 2026-05-14
-$4.32M
derived: sum of 3 quarters · filed 2026-05-14
-$8.41M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31-$289.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
-$3.98M
derived: sum of 2 quarters · filed 2026-03-27
-$8.06M
derived: sum of 3 quarters · filed 2026-03-27
-$11.36M
10-K · filed 2026-03-27
2024-09-30-$3.69M
10-Q · filed 2025-11-12
-$7.78M
derived: sum of 2 quarters · filed 2025-11-12
-$11.07M
10-Q · filed 2025-11-12
-$14.45M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30-$4.09M
10-Q · filed 2025-08-14
-$7.39M
10-Q · filed 2025-08-14
-$10.76M
derived: sum of 3 quarters · filed 2025-08-14
-$14.84M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31-$3.30M
10-Q · filed 2025-05-15
-$6.67M
derived: sum of 2 quarters · filed 2025-05-15
-$10.75M
derived: sum of 3 quarters · filed 2025-05-15
-$14.11M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31-$3.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24
-$7.45M
derived: sum of 2 quarters · filed 2025-03-24
-$10.81M
derived: sum of 3 quarters · filed 2025-03-24
-$15.09M
10-K · filed 2025-03-24
2023-09-30-$4.08M
10-Q · filed 2024-11-14
-$7.43M
derived: sum of 2 quarters · filed 2024-11-14
-$11.72M
10-Q · filed 2024-11-14
-$15.83M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$3.35M
10-Q · filed 2024-08-12
-$7.64M
10-Q · filed 2024-08-12
-$11.75M
derived: sum of 3 quarters · filed 2024-08-12
-$15.56M
derived: sum of 4 quarters · filed 2024-08-12
2023-03-31-$4.28M
10-Q · filed 2024-05-13
-$8.39M
derived: sum of 2 quarters · filed 2024-05-13
-$12.20M
derived: sum of 3 quarters · filed 2024-05-13
-$15.78M
derived: sum of 4 quarters · filed 2024-05-13
2022-12-31-$4.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25
-$7.92M
derived: sum of 2 quarters · filed 2024-03-25
-$11.49M
derived: sum of 3 quarters · filed 2024-03-25
-$14.26M
10-K · filed 2024-03-25
2022-09-30-$3.81M
10-Q · filed 2023-11-13
-$7.38M
derived: sum of 2 quarters · filed 2023-11-13
-$10.14M
10-Q · filed 2023-11-13
-$12.60M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30-$3.58M
10-Q · filed 2023-08-14
-$6.34M
10-Q · filed 2023-08-14
-$8.80M
derived: sum of 3 quarters · filed 2023-08-14
-$10.24M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$2.76M
10-Q · filed 2023-05-15
-$5.22M
derived: sum of 2 quarters · filed 2023-05-15
-$6.66M
derived: sum of 3 quarters · filed 2023-05-15
-$7.86M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$2.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14
-$3.90M
derived: sum of 2 quarters · filed 2023-03-14
-$5.10M
derived: sum of 3 quarters · filed 2023-03-14
-$5.78M
10-K · filed 2023-03-14
2021-09-30-$1.44M
10-Q · filed 2022-11-14
-$2.64M
derived: sum of 2 quarters · filed 2022-11-14
-$3.32M
10-Q · filed 2022-11-14
-$3.84M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$1.20M
10-Q · filed 2022-08-15
-$1.88M
10-Q · filed 2022-08-15
-$2.40M
derived: sum of 3 quarters · filed 2022-08-15
-$2.79M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31-$679.00K
10-Q · filed 2022-05-16
-$1.20M
derived: sum of 2 quarters · filed 2022-05-16
-$1.59M
derived: sum of 3 quarters · filed 2022-05-16
-$1.85M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31-$519.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06
-$910.00K
derived: sum of 2 quarters · filed 2022-04-06
-$1.18M
derived: sum of 3 quarters · filed 2022-04-06
-$1.61M
10-K · filed 2022-04-06
2020-09-30-$391.00K
10-Q · filed 2021-11-22
-$657.00K
derived: sum of 2 quarters · filed 2021-11-22
-$1.09M
10-Q · filed 2021-11-22
-$1.40M
derived: sum of 4 quarters · filed 2021-11-22
2020-06-30-$266.00K
10-Q · filed 2021-08-16
-$702.00K
10-Q · filed 2021-08-16
-$1.01M
derived: sum of 3 quarters · filed 2021-08-16
-$1.20M
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31-$436.00K
10-Q · filed 2021-05-17
-$746.00K
derived: sum of 2 quarters · filed 2021-05-17
-$932.00K
derived: sum of 3 quarters · filed 2021-05-17
-$1.08M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31-$310.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15
-$496.00K
derived: sum of 2 quarters · filed 2021-03-15
-$641.00K
derived: sum of 3 quarters · filed 2021-03-15
-$811.00K
10-K · filed 2021-03-15
-$810.89K
10-K · filed 2020-04-14
2019-09-30-$186.00K
10-Q · filed 2020-11-06
-$186.35K
10-Q · filed 2019-11-19
-$331.00K
derived: sum of 2 quarters · filed 2020-11-06
-$501.00K
10-Q · filed 2020-11-06
-$500.62K
10-Q · filed 2019-11-19
-$590.44K
derived: sum of 4 quarters · filed 2020-11-06
2019-06-30-$145.00K
10-Q · filed 2020-08-14
-$145.52K
10-Q · filed 2019-08-14
-$314.00K
10-Q · filed 2020-08-14
-$314.27K
10-Q · filed 2019-08-14
-$404.44K
derived: sum of 3 quarters · filed 2020-08-14
-$436.87K
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31-$169.00K
10-Q · filed 2020-05-28
-$168.75K
10-Q · filed 2019-05-15
-$259.44K
derived: sum of 2 quarters · filed 2020-05-28
-$291.87K
derived: sum of 3 quarters · filed 2020-05-28
-$373.07K
derived: sum of 4 quarters · filed 2020-05-28
2018-12-31-$90.44K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-14
-$122.87K
derived: sum of 2 quarters · filed 2020-04-14
-$204.07K
derived: sum of 3 quarters · filed 2020-04-14
-$204.07K
10-K · filed 2020-04-14
2018-09-30-$32.43K
10-Q · filed 2019-11-19
-$113.63K
derived: sum of 2 quarters · filed 2019-11-19
-$113.63K
10-Q · filed 2019-11-19
2018-06-30-$81.20K
10-Q · filed 2019-08-14
$81.20K
10-Q · filed 2018-08-13
-$81.20K
10-Q · filed 2019-08-14
$81.20K
10-Q · filed 2018-08-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
InspireMD, Inc. (NSPR)$0.033B
Glucotrack, Inc. (GCTK)United States$0.027B
ACCURAY INC (ARAY)United States$0.027B-0.63
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
Modular Medical, Inc. (MODD)United States$0.018B-0.88
NEPHROS INC (NEPH)United States$0.046B23.02
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14